The Real GLP-1 Debate: Is Obesity A ‘Disease?’

 
• By Michael McCaughan
  
Will the Trump Administration rescind the Medicare anti-obesity medication coverage proposed rule? Past comments suggest the answer is not clear cut. (Shutterstock)

More from Medicare

More from Market Access